While the sting of most scorpions is nonlethal to humans, it's not usually considered health-enhancing either. But the venom could actually prove lifesaving.
While the sting of most scorpions is nonlethal to humans, it's not usually considered health-enhancing either. But the venom could actually prove lifesaving.
Dr. James M. Olson and colleagues at the Fred Hutchinson Cancer Research Center in Seattle attached the peptide chlorotoxin to Cy5.5, a fluorescent molecule that emits near-infrared light. Chlorotoxin, a component of scorpion venom, preferentially binds to cancer cells (Cancer Res 2007;67:6882-6888).
The probe lit up malignant gliomas, medulloblastomas, prostate cancer, intestinal cancer, and sarcomas. Brain tumors as small as 1 mm in diameter and as few as 200 metastatic prostate cancer cells were visualized.
The unique contrast agent shows promise for imaging melanoma and skin, esophageal, cervical, lung, and colon cancers. It binds to cancer cells within minutes after injection, but its signal can be detected for 14 days. Iron oxide-based nanoparticles coated with chlorotoxin imaging are being developed for use with MR.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.